コンパニオンアニマル用動物用ワクチンの世界市場レポート 2025年

コンパニオンアニマル用動物用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0％で50億9,000万米ドルに成長します。予測期間の成長は、ペット人口の増加、予防ヘルスケア意識、技術およびワクチン開発、カスタマイズされたワクチン接種計画に起因します。予測期間における主な動向は、包括的なワクチン接種プログラム、先進的なワクチン技術、媒介感染症対策、ワクチンクリニック、モバイルサービスなどです。

コンパニオンアニマル用動物ワクチン市場の予測期間中の成長は、X世代とY世代の成人におけるペット飼育の増加によってもたらされます。APPAによると、ミレニアル世代（Y世代）は、ペットの種類を問わず、最大のペット所有者グループを構成しています。Y世代とZ世代の80％以上が犬を飼っているが、猫を飼っているのは50％未満です。さらに、ペットの複数飼いの動向は世界的にますます一般化しています。例えば、オーストラリアを拠点とする非政府組織、アニマル・メディシンズ・オーストラリアが2022年に報告したように、オーストラリアではペットの飼育数が大幅に増加しました。2021年には39％であったペットの飼い主数は、2022年には28,730.8人に達し、24％の増加と、ペットの養子縁組と世話への投資の力強い増加傾向を反映しています。このペット飼育数の増加は、オーストラリアの家庭におけるペット人気の高まりを浮き彫りにし、コンパニオンアニマル用動物ワクチン市場の拡大に寄与しています。

コンパニオンアニマル用動物用ワクチン市場の成長は、ペットの健康に対する支出の増加によってさらに促進されます。ペットの健康は、犬、猫、鳥、小型哺乳類、その他の飼われているペットを含む動物の全体的な幸福のために不可欠です。定期的なワクチン接種は予防ペットのヘルスケアの要であり、個々のペットの健康だけでなく、より広いペット社会にも利益をもたらしています。2023年6月、米国ペット用品協会（American Pet Products Association）は、2022年に米国人がペットの健康に費やした金額は1,368億米ドルで、1,236億米ドルだった2021年から10.68％増加したと報告しました。また、ペットフードやおやつの売上は581億米ドルでした。このようにペットの健康への支出が増加傾向にあることが、コンパニオンアニマル用動物用ワクチン市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界コンパニオンアニマル用動物用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコンパニオンアニマル用動物用ワクチン市場：成長率分析
• 世界のコンパニオンアニマル用動物用ワクチン市場の実績：規模と成長, 2019-2024
• 世界のコンパニオンアニマル用動物用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界コンパニオンアニマル用動物用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコンパニオンアニマル用動物用ワクチン市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活性化
• 生弱毒化
• 組み換え
• その他の製品
• 世界のコンパニオンアニマル用動物用ワクチン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界のコンパニオンアニマル用動物用ワクチン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 獣医クリニック
• 薬局とドラッグストア
• その他の流通チャネル
• 世界のコンパニオンアニマル用動物用ワクチン市場、不活性化のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化犬ワクチン
• 不活化猫ワクチン
• 不活化ワクチンの組み合わせ
• その他の不活化ワクチン
• 世界のコンパニオンアニマル用動物用ワクチン市場、生弱毒化菌のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化犬ワクチン
• 生弱毒化猫ワクチン
• 生弱毒化ワクチンの組み合わせ
• その他の生弱毒化ワクチン
• 世界のコンパニオンアニマル用動物用ワクチン市場、組換え体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え犬ワクチン
• 組み換え猫ワクチン
• 組み換えワクチンの組み合わせ
• その他の組み換えワクチン
• 世界のコンパニオンアニマル用動物用ワクチン市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAワクチン
• サブユニットワクチン
• トキソイドワクチン
• その他の獣医用ワクチン製品

第7章 地域別・国別分析

• 世界のコンパニオンアニマル用動物用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコンパニオンアニマル用動物用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コンパニオンアニマル用動物用ワクチン市場：競合情勢
• コンパニオンアニマル用動物用ワクチン市場：企業プロファイル
  • C.H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Heska Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zoetis Inc.
• Ceva Sante Animale SA
• Bayer AG
• Neogen Corporation
• ImmuCell Corporation
• Intervet Inc.
• Vetoquinol SA
• IDEXX Laboratories Inc.
• Merial Inc.
• Biogenesis Bago SA
• Hipra India Pvt. Ltd.
• Bimeda Animal Health Limited
• Phibro Animal Health Corporation
• Nexvet Biopharma plc
• Bioniche Animal Health Canada Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コンパニオンアニマル用動物用ワクチン市場2029：新たな機会を提供する国
• コンパニオンアニマル用動物用ワクチン市場2029：新たな機会を提供するセグメント
• コンパニオンアニマル用動物用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Companion animal vaccines are substances designed to stimulate the production of antibodies and confer immunity against one or more diseases in pets, including dogs, birds, and cats. They serve not only to protect against diseases but also to enhance food digestion, boost immunity, promote weight gain, and generate high-quality meat for commercial purposes.

The primary types of companion animal veterinary vaccines are inactivated, live attenuated, recombinant, and other products. Recombinant vaccines are created using recombinant DNA technology, involving the insertion of DNA encoding an antigen (e.g., a bacterial surface protein) into bacterial or mammalian cells, expression of the antigen within these cells, and subsequent purification. These products can be administered through oral, parenteral, and other routes of administration and are distributed through various channels, including veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other distribution channels.

The companion animal veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides companion animal veterinary vaccines statistics, including companion animal veterinary vaccines industry global market size, regional shares, competitors with companion animal veterinary vaccines share, detailed companion animal veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the companion animal veterinary vaccines industry. This companion animal veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal veterinary vaccines market size has grown strongly in recent years. It will grow from $3.66 billion in 2024 to $3.88 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to pet ownership growth, preventive healthcare, zoonotic diseases, advancements in vaccine technology.

The companion animal veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing pet population, preventive healthcare awareness, technology and vaccine development, customized vaccination plans. Major trends in the forecast period include comprehensive vaccination programs, advanced vaccine technologies, vector-borne disease control, vaccination clinics and mobile services.

The growth of the companion animal veterinary vaccine market during the forecast period is driven by the increasing pet ownership among Gen X and Gen Y adults. According to the APPA, millennials (Gen Y) constitute the largest group of pet owners across different types of pets. Over 80% of Gen Y and Gen Z individuals own dogs, while fewer than 50% own cats. Additionally, the trend of multiple pet ownership is becoming increasingly common worldwide. For example, in 2022, as reported by Animal Medicines Australia, an Australia-based non-governmental organization, pet ownership in Australia saw significant growth. The number of pet owners reached 28,730.8 in 2022, compared to 39% in 2021, reflecting a 24% increase and a strong upward trend in pet adoption and care investment. This rise in pet ownership highlights the growing popularity of pets in Australian households and contributes to the expansion of the companion animal veterinary vaccine market.

The growth of the companion animal veterinary vaccines market is further driven by the increasing expenditure on pet health. Pet health is vital for the overall well-being of animals, including dogs, cats, birds, small mammals, and other domesticated pets. Regular vaccinations are a cornerstone of preventive pet healthcare, benefiting not only individual pet health but also the broader pet community. In June 2023, the American Pet Products Association reported that Americans spent $136.8 billion on pet health in 2022, representing a 10.68% increase from 2021, when spending amounted to $123.6 billion. Additionally, sales of pet food and treats accounted for $58.1 billion. This upward trajectory in pet health spending is propelling the growth of the companion animal veterinary vaccines market.

Companies operating in the companion animal veterinary vaccine industry are increasingly engaging in collaborations and partnerships to drive product innovations. To thrive in the competitive veterinary market, these companies are expanding into new geographic regions and developing innovative products by leveraging their skills and expertise through partnerships with other players. For example, Merck & Co.'s subsidiary, MSD Animal Health, has established a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, a leading hatchery automation company. This partnership aims to set a new standard in safe and effective Vinovo vaccination, enhancing bird welfare and reducing vaccine reactions.

Leading companies in the companion animal vaccine market are introducing innovative vaccines to enhance their market presence and revenue. For instance, in September 2022, Merck Animal Health (MSD Animal Health), a US-based animal pharmaceutical manufacturer, launched Nobivac Intra-Trac Oral BbPi, an oral vaccine designed to protect dogs against Bordetella bronchiseptica and canine parainfluenza virus. This groundbreaking vaccine, the first of its kind, provides mucosal immunity via the proprietary Immuno-Mist-R(TM) delivery system, ensuring comprehensive spray coverage. This innovation simplifies administration for veterinarians while improving comfort for dogs. Designed for dogs aged seven weeks and older, it is both thimerosal-free and preservative-free, prioritizing safety while streamlining the protection of canine respiratory health.

In June 2023, Mars Inc., a US-based manufacturing company, acquired Heska Corp. for $1.3 billion. This acquisition bolsters Mars Petcare's veterinary care offerings and underscores its commitment to advancing pet health. Heska is now integrated into Mars Petcare's science and diagnostics division, which includes Antech Diagnostics. This integration enhances diagnostic capabilities for veterinary professionals and pet owners by expanding access to advanced diagnostic technologies and accelerating research and development in veterinary healthcare. Heska Corp., a US-based veterinary services company, specializes in developing, manufacturing, and commercializing advanced veterinary diagnostics and vaccines for canine and feline health.

Major companies operating in the companion animal veterinary vaccines market include C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, Heska Corp., Merck and Co. Inc., Elanco Animal Health Incorporated, Zoetis Inc., Ceva Sante Animale SA, Bayer AG, Neogen Corporation, ImmuCell Corporation, Intervet Inc., Vetoquinol SA, IDEXX Laboratories Inc., Merial Inc., Biogenesis Bago SA, Hipra India Pvt. Ltd., Bimeda Animal Health Limited, Phibro Animal Health Corporation, Nexvet Biopharma plc, Bioniche Animal Health Canada Inc., Bioiberica S.A., Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Dechra Pharmaceuticals PLC, Kyoritsu Seiyaku Corporation, VDS Pharma Animal Health, Kepro Technologies Private Limited, ECO Animal Health Group plc, Biostadt India Limited, bio-pharmaceutical company, Choong Ang Vaccine Laboratories Co. Ltd., CZ Veterinaria S.A.

North America was the largest region in the companion animal veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the companion animal veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The companion animal veterinary vaccine market consists of sales of toxoid vaccines, viral vector vaccines, messenger RNA vaccines, and conjugated vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Veterinary Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The companion animal veterinary vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Inactivated; Live Attenuated; Recombinant; Other Products
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores; Other Distribution Channels
• Subsegments:
• 1) By Inactivated: Inactivated Canine Vaccines; Inactivated Feline Vaccines; Inactivated Vaccine Combinations; Other Inactivated Vaccines
• 2) By Live Attenuated: Live Attenuated Canine Vaccines; Live Attenuated Feline Vaccines; Live Attenuated Vaccine Combinations; Other Live Attenuated Vaccines
• 3) By Recombinant: Recombinant Canine Vaccines; Recombinant Feline Vaccines; Recombinant Vaccine Combinations; Other Recombinant Vaccines
• 4) By Other Products: DNA Vaccines; Subunit Vaccines; Toxoid Vaccines; Other Veterinary Vaccine Products
• Companies Mentioned: C.H. Boehringer Sohn AG & Co. KG; Eli Lilly and Company; Heska Corp.; Merck and Co. Inc.; Elanco Animal Health Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Companion Animal Veterinary Vaccines Market Characteristics

3. Companion Animal Veterinary Vaccines Market Trends And Strategies

4. Companion Animal Veterinary Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Companion Animal Veterinary Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Companion Animal Veterinary Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Companion Animal Veterinary Vaccines Market Growth Rate Analysis
• 5.4. Global Companion Animal Veterinary Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Companion Animal Veterinary Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Companion Animal Veterinary Vaccines Total Addressable Market (TAM)

6. Companion Animal Veterinary Vaccines Market Segmentation

• 6.1. Global Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated
• Live Attenuated
• Recombinant
• Other Products
• 6.2. Global Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.3. Global Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Other Distribution Channels
• 6.4. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Canine Vaccines
• Inactivated Feline Vaccines
• Inactivated Vaccine Combinations
• Other Inactivated Vaccines
• 6.5. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Canine Vaccines
• Live Attenuated Feline Vaccines
• Live Attenuated Vaccine Combinations
• Other Live Attenuated Vaccines
• 6.6. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Recombinant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Canine Vaccines
• Recombinant Feline Vaccines
• Recombinant Vaccine Combinations
• Other Recombinant Vaccines
• 6.7. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Other Veterinary Vaccine Products

7. Companion Animal Veterinary Vaccines Market Regional And Country Analysis

• 7.1. Global Companion Animal Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Companion Animal Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Companion Animal Veterinary Vaccines Market

• 8.1. Asia-Pacific Companion Animal Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Companion Animal Veterinary Vaccines Market

• 9.1. China Companion Animal Veterinary Vaccines Market Overview
• 9.2. China Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Companion Animal Veterinary Vaccines Market

• 10.1. India Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Companion Animal Veterinary Vaccines Market

• 11.1. Japan Companion Animal Veterinary Vaccines Market Overview
• 11.2. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Companion Animal Veterinary Vaccines Market

• 12.1. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Companion Animal Veterinary Vaccines Market

• 13.1. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Companion Animal Veterinary Vaccines Market

• 14.1. South Korea Companion Animal Veterinary Vaccines Market Overview
• 14.2. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Companion Animal Veterinary Vaccines Market

• 15.1. Western Europe Companion Animal Veterinary Vaccines Market Overview
• 15.2. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Companion Animal Veterinary Vaccines Market

• 16.1. UK Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Companion Animal Veterinary Vaccines Market

• 17.1. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Companion Animal Veterinary Vaccines Market

• 18.1. France Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Companion Animal Veterinary Vaccines Market

• 19.1. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Companion Animal Veterinary Vaccines Market

• 20.1. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Companion Animal Veterinary Vaccines Market

• 21.1. Eastern Europe Companion Animal Veterinary Vaccines Market Overview
• 21.2. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Companion Animal Veterinary Vaccines Market

• 22.1. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Companion Animal Veterinary Vaccines Market

• 23.1. North America Companion Animal Veterinary Vaccines Market Overview
• 23.2. North America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Companion Animal Veterinary Vaccines Market

• 24.1. USA Companion Animal Veterinary Vaccines Market Overview
• 24.2. USA Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Companion Animal Veterinary Vaccines Market

• 25.1. Canada Companion Animal Veterinary Vaccines Market Overview
• 25.2. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Companion Animal Veterinary Vaccines Market

• 26.1. South America Companion Animal Veterinary Vaccines Market Overview
• 26.2. South America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Companion Animal Veterinary Vaccines Market

• 27.1. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Companion Animal Veterinary Vaccines Market

• 28.1. Middle East Companion Animal Veterinary Vaccines Market Overview
• 28.2. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Companion Animal Veterinary Vaccines Market

• 29.1. Africa Companion Animal Veterinary Vaccines Market Overview
• 29.2. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Companion Animal Veterinary Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Companion Animal Veterinary Vaccines Market Competitive Landscape
• 30.2. Companion Animal Veterinary Vaccines Market Company Profiles
  • 30.2.1. C.H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Heska Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Companion Animal Veterinary Vaccines Market Other Major And Innovative Companies

• 31.1. Zoetis Inc.
• 31.2. Ceva Sante Animale SA
• 31.3. Bayer AG
• 31.4. Neogen Corporation
• 31.5. ImmuCell Corporation
• 31.6. Intervet Inc.
• 31.7. Vetoquinol SA
• 31.8. IDEXX Laboratories Inc.
• 31.9. Merial Inc.
• 31.10. Biogenesis Bago SA
• 31.11. Hipra India Pvt. Ltd.
• 31.12. Bimeda Animal Health Limited
• 31.13. Phibro Animal Health Corporation
• 31.14. Nexvet Biopharma plc
• 31.15. Bioniche Animal Health Canada Inc.

32. Global Companion Animal Veterinary Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Veterinary Vaccines Market

34. Recent Developments In The Companion Animal Veterinary Vaccines Market

35. Companion Animal Veterinary Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Companion Animal Veterinary Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Companion Animal Veterinary Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Companion Animal Veterinary Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer